欧洲未知肝病成人中肝纤维化高患病率:一项基于人群的研究
在巴塞罗那都市区开展基于人群的横断面研究,随机邀请4866名18至75岁居民,3076人参与(63.2%),用瞬时弹性成像测肝硬度评估肝纤维化。肝硬度升高(≥6.8、≥8.0、≥9.0 kPa)的患病率分别为9.0%、5.8%、3.6%,病因主要为非酒精性脂肪性肝病(NAFLD),其次为酒精风险消费。显著肝纤维化(F2-F4)的最佳肝硬度截断值为9.2 kPa,敏感度和特异度均高,肝硬度<9.2 kPa可高准确度预测无显著肝纤维化,可用于筛查。
要点
- 肝硬度≥6.8、≥8.0、≥9.0 kPa的患病率分别为9.0%、5.8%、3.6%。
- 肝病病因主要为NAFLD,其次为酒精风险消费。
- 显著肝纤维化(F2-F4)最佳肝硬度截断值为9.2 kPa,敏感度和特异度均高。
核心结论
- 欧洲无已知肝病成人中沉默性肝病伴进展期纤维化患病率高,主要与NAFLD相关。
- 肝硬度<9.2 kPa可高准确度预测无显著肝纤维化,可用于筛查目的。
研究设计与样本
- 基于人群的横断面研究,在巴塞罗那都市区开展。
- 从初级卫生保健登记居民中随机识别18至75岁受试者。
- 邀请4866名受试者,3076人参与(63.2%)。
- 用瞬时弹性成像(TE)测肝硬度评估肝纤维化,对92名肝硬度升高者评估肝组织学。
主要发现
- 肝硬度升高(≥6.8、≥8.0、≥9.0 kPa)的患病率分别为9.0%、5.8%、3.6%。
- 肝病病因主要为NAFLD,其次为酒精风险消费(男性每周≥21标准饮酒单位、女性每周≥14标准饮酒单位)。
- 与肝硬度升高独立相关的因素为男性、腹型肥胖、2型糖尿病、血清葡萄糖、高密度脂蛋白和甘油三酯水平。
- 无NAFLD危险因素或无酒精风险消费的受试者肝硬度升高患病率极低。
- 显著肝纤维化(F2-F4)的最佳肝硬度截断值为9.2 kPa,敏感度和特异度均高。
关键数值与推荐
- 肝硬度≥6.8 kPa为肝硬度升高,患病率9.0%。
- 肝硬度≥8.0 kPa为肝硬度升高,患病率5.8%。
- 肝硬度≥9.0 kPa为肝硬度升高,患病率3.6%。
- 显著肝纤维化(F2-F4)的最佳肝硬度截断值为9.2 kPa,敏感度和特异度均高。
- 酒精风险消费定义为男性每周≥21标准饮酒单位、女性每周≥14标准饮酒单位。
临床怎么用
- 作者提出在社区环境中用TE筛查肝纤维化的算法。
- 肝硬度<9.2 kPa可高准确度预测无显著肝纤维化,可用于筛查目的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Liver fibrosis is the main determinant of long-term outcome in chronic liver diseases. Little is known about the prevalence of liver fibrosis in the general population. The aim of the study was to investigate the prevalence of liver fibrosis in the general adult population with unknown liver disease. METHODS: This was a population-based, cross-sectional study performed in the Barcelona metropolitan area. Subjects aged 18 to 75 years old were identified randomly from citizens included in the primary health care registry. Of 4866 subjects invited, 3076 participated (63.2%). Liver fibrosis was estimated by measuring liver stiffness (LS) with transient elastography (TE). Liver histology was assessed in 92 subjects with increased LS. RESULTS: Prevalence estimates of increased LS (≥6.8, ≥8.0, and ≥9.0 kPa) were 9.0%, 5.8%, and 3.6%, respectively. The etiology of liver disease was mainly nonalcoholic fatty liver disease (NAFLD), followed by alcohol risk consumption (consumption of ≥21 standard drinking units/wk in men and ≥14 standard drinking units/wk in women). Factors independently associated with increased LS were male sex, abdominal obesity, type 2 diabetes, serum glucose, high-density lipoprotein, and triglyceride levels. Subjects without risk factors for NAFLD or without alcohol risk consumption had a very low prevalence of increased LS. The best cut-off value of LS for significant liver fibrosis (F2-F4) was 9.2 kPa, with high sensitivity and specificity. TE was more accurate than alanine aminotransferase, NAFLD fibrosis score, or Fibrosis 4. An algorithm for screening for liver fibrosis using TE in the community setting is proposed. CONCLUSIONS: These findings show a high prevalence of silent liver disease with advanced fibrosis mainly related to NAFLD in adult European subjects without known liver disease. An LS value less than 9.2 kPa predicts the absence of significant liver fibrosis with high accuracy and could be used for screening purposes.
引用
- Caballería L, Pera G, Arteaga I, et al. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study. Clin Gastroenterol Hepatol. 2018. PMID: 29452268. doi:10.1016/j.cgh.2017.12.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。